
The global Threonine market size was US$ 1716 million in 2024 and is forecast to a readjusted size of US$ 2900 million by 2031 with a CAGR of 7.9% during the forecast period 2025-2031.
Threonine is a type of α-amino acid with the chemical formula HO2CCH(NH2)CH(OH)CH3. Threonine have four kinds of isomer, natural existence and have physiological role for organism is L - threonine. And this report data refers to L-threonine.
Asia-Pacific is the largest producer of Threonine, with a market share about 55%. It was followed by Europe with 25%. Meihua, Ajinomoto Group, CJ CheilJedang, Evonik and Fufeng are the top 5 manufacturers of industry, and they had about 80% combined market share.
The global Threonine market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Âé¶¹Ô´´ Segmentation
By Company:
Meihua
Ajinomoto Group
CJ CheilJedang
Evonik
Fufeng
NB Group
Star Lake Bioscience
Guoguang Biochemistry
GLOBAL Bio-Chem
ADM
By Type: (Dominant Segment vs High-Margin Innovation)
Pharmaceutical Grade
Food Grade
Feed Grade
By Application: (Core Demand Driver vs Emerging Opportunity)
Pharmaceutical Industry
Food Industry
Feed Industry
By Region
Macro-Regional Analysis: Âé¶¹Ô´´ Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Âé¶¹Ô´´ Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Meihua in Europe)
- Emerging Product Trends: Pharmaceutical Grade adoption vs. Food Grade premiumization
- Demand-Side Dynamics: Pharmaceutical Industry growth in China vs. Food Industry potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Âé¶¹Ô´´s:
North America
Europe
China
Japan
South Korea
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Threonine market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Food Grade in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Food Industry in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Âé¶¹Ô´´ dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Threonine value chain, addressing:
- Âé¶¹Ô´´ entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Âé¶¹Ô´´ Overview
1.1 Threonine Product Scope
1.2 Threonine by Type
1.2.1 Global Threonine Sales by Type (2020 & 2024 & 2031)
1.2.2 Pharmaceutical Grade
1.2.3 Food Grade
1.2.4 Feed Grade
1.3 Threonine by Application
1.3.1 Global Threonine Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Pharmaceutical Industry
1.3.3 Food Industry
1.3.4 Feed Industry
1.4 Global Threonine Âé¶¹Ô´´ Estimates and Forecasts (2020-2031)
1.4.1 Global Threonine Âé¶¹Ô´´ Size in Value Growth Rate (2020-2031)
1.4.2 Global Threonine Âé¶¹Ô´´ Size in Volume Growth Rate (2020-2031)
1.4.3 Global Threonine Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Âé¶¹Ô´´ Size and Prospective by Region
2.1 Global Threonine Âé¶¹Ô´´ Size by Region: 2020 VS 2024 VS 2031
2.2 Global Threonine Retrospective Âé¶¹Ô´´ Scenario by Region (2020-2025)
2.2.1 Global Threonine Sales Âé¶¹Ô´´ Share by Region (2020-2025)
2.2.2 Global Threonine Revenue Âé¶¹Ô´´ Share by Region (2020-2025)
2.3 Global Threonine Âé¶¹Ô´´ Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Threonine Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Threonine Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Âé¶¹Ô´´ Analysis
2.4.1 North America Threonine Âé¶¹Ô´´ Size and Prospective (2020-2031)
2.4.2 Europe Threonine Âé¶¹Ô´´ Size and Prospective (2020-2031)
2.4.3 China Threonine Âé¶¹Ô´´ Size and Prospective (2020-2031)
2.4.4 Japan Threonine Âé¶¹Ô´´ Size and Prospective (2020-2031)
2.4.5 South Korea Threonine Âé¶¹Ô´´ Size and Prospective (2020-2031)
3 Global Âé¶¹Ô´´ Size by Type
3.1 Global Threonine Historic Âé¶¹Ô´´ Review by Type (2020-2025)
3.1.1 Global Threonine Sales by Type (2020-2025)
3.1.2 Global Threonine Revenue by Type (2020-2025)
3.1.3 Global Threonine Price by Type (2020-2025)
3.2 Global Threonine Âé¶¹Ô´´ Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Threonine Sales Forecast by Type (2026-2031)
3.2.2 Global Threonine Revenue Forecast by Type (2026-2031)
3.2.3 Global Threonine Price Forecast by Type (2026-2031)
3.3 Different Types Threonine Representative Players
4 Global Âé¶¹Ô´´ Size by Application
4.1 Global Threonine Historic Âé¶¹Ô´´ Review by Application (2020-2025)
4.1.1 Global Threonine Sales by Application (2020-2025)
4.1.2 Global Threonine Revenue by Application (2020-2025)
4.1.3 Global Threonine Price by Application (2020-2025)
4.2 Global Threonine Âé¶¹Ô´´ Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Threonine Sales Forecast by Application (2026-2031)
4.2.2 Global Threonine Revenue Forecast by Application (2026-2031)
4.2.3 Global Threonine Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Threonine Application
5 Competition Landscape by Players
5.1 Global Threonine Sales by Players (2020-2025)
5.2 Global Top Threonine Players by Revenue (2020-2025)
5.3 Global Threonine Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Threonine as of 2024)
5.4 Global Threonine Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Threonine, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Threonine, Product Type & Application
5.7 Global Key Manufacturers of Threonine, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Âé¶¹Ô´´: Players, Segments, Downstream and Major Customers
6.1.1 North America Threonine Sales by Company
6.1.1.1 North America Threonine Sales by Company (2020-2025)
6.1.1.2 North America Threonine Revenue by Company (2020-2025)
6.1.2 North America Threonine Sales Breakdown by Type (2020-2025)
6.1.3 North America Threonine Sales Breakdown by Application (2020-2025)
6.1.4 North America Threonine Major Customer
6.1.5 North America Âé¶¹Ô´´ Trend and Opportunities
6.2 Europe Âé¶¹Ô´´: Players, Segments, Downstream and Major Customers
6.2.1 Europe Threonine Sales by Company
6.2.1.1 Europe Threonine Sales by Company (2020-2025)
6.2.1.2 Europe Threonine Revenue by Company (2020-2025)
6.2.2 Europe Threonine Sales Breakdown by Type (2020-2025)
6.2.3 Europe Threonine Sales Breakdown by Application (2020-2025)
6.2.4 Europe Threonine Major Customer
6.2.5 Europe Âé¶¹Ô´´ Trend and Opportunities
6.3 China Âé¶¹Ô´´: Players, Segments, Downstream and Major Customers
6.3.1 China Threonine Sales by Company
6.3.1.1 China Threonine Sales by Company (2020-2025)
6.3.1.2 China Threonine Revenue by Company (2020-2025)
6.3.2 China Threonine Sales Breakdown by Type (2020-2025)
6.3.3 China Threonine Sales Breakdown by Application (2020-2025)
6.3.4 China Threonine Major Customer
6.3.5 China Âé¶¹Ô´´ Trend and Opportunities
6.4 Japan Âé¶¹Ô´´: Players, Segments, Downstream and Major Customers
6.4.1 Japan Threonine Sales by Company
6.4.1.1 Japan Threonine Sales by Company (2020-2025)
6.4.1.2 Japan Threonine Revenue by Company (2020-2025)
6.4.2 Japan Threonine Sales Breakdown by Type (2020-2025)
6.4.3 Japan Threonine Sales Breakdown by Application (2020-2025)
6.4.4 Japan Threonine Major Customer
6.4.5 Japan Âé¶¹Ô´´ Trend and Opportunities
6.5 South Korea Âé¶¹Ô´´: Players, Segments, Downstream and Major Customers
6.5.1 South Korea Threonine Sales by Company
6.5.1.1 South Korea Threonine Sales by Company (2020-2025)
6.5.1.2 South Korea Threonine Revenue by Company (2020-2025)
6.5.2 South Korea Threonine Sales Breakdown by Type (2020-2025)
6.5.3 South Korea Threonine Sales Breakdown by Application (2020-2025)
6.5.4 South Korea Threonine Major Customer
6.5.5 South Korea Âé¶¹Ô´´ Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Meihua
7.1.1 Meihua Company Information
7.1.2 Meihua Business Overview
7.1.3 Meihua Threonine Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Meihua Threonine Products Offered
7.1.5 Meihua Recent Development
7.2 Ajinomoto Group
7.2.1 Ajinomoto Group Company Information
7.2.2 Ajinomoto Group Business Overview
7.2.3 Ajinomoto Group Threonine Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Ajinomoto Group Threonine Products Offered
7.2.5 Ajinomoto Group Recent Development
7.3 CJ CheilJedang
7.3.1 CJ CheilJedang Company Information
7.3.2 CJ CheilJedang Business Overview
7.3.3 CJ CheilJedang Threonine Sales, Revenue and Gross Margin (2020-2025)
7.3.4 CJ CheilJedang Threonine Products Offered
7.3.5 CJ CheilJedang Recent Development
7.4 Evonik
7.4.1 Evonik Company Information
7.4.2 Evonik Business Overview
7.4.3 Evonik Threonine Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Evonik Threonine Products Offered
7.4.5 Evonik Recent Development
7.5 Fufeng
7.5.1 Fufeng Company Information
7.5.2 Fufeng Business Overview
7.5.3 Fufeng Threonine Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Fufeng Threonine Products Offered
7.5.5 Fufeng Recent Development
7.6 NB Group
7.6.1 NB Group Company Information
7.6.2 NB Group Business Overview
7.6.3 NB Group Threonine Sales, Revenue and Gross Margin (2020-2025)
7.6.4 NB Group Threonine Products Offered
7.6.5 NB Group Recent Development
7.7 Star Lake Bioscience
7.7.1 Star Lake Bioscience Company Information
7.7.2 Star Lake Bioscience Business Overview
7.7.3 Star Lake Bioscience Threonine Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Star Lake Bioscience Threonine Products Offered
7.7.5 Star Lake Bioscience Recent Development
7.8 Guoguang Biochemistry
7.8.1 Guoguang Biochemistry Company Information
7.8.2 Guoguang Biochemistry Business Overview
7.8.3 Guoguang Biochemistry Threonine Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Guoguang Biochemistry Threonine Products Offered
7.8.5 Guoguang Biochemistry Recent Development
7.9 GLOBAL Bio-Chem
7.9.1 GLOBAL Bio-Chem Company Information
7.9.2 GLOBAL Bio-Chem Business Overview
7.9.3 GLOBAL Bio-Chem Threonine Sales, Revenue and Gross Margin (2020-2025)
7.9.4 GLOBAL Bio-Chem Threonine Products Offered
7.9.5 GLOBAL Bio-Chem Recent Development
7.10 ADM
7.10.1 ADM Company Information
7.10.2 ADM Business Overview
7.10.3 ADM Threonine Sales, Revenue and Gross Margin (2020-2025)
7.10.4 ADM Threonine Products Offered
7.10.5 ADM Recent Development
8 Threonine Manufacturing Cost Analysis
8.1 Threonine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Threonine
8.4 Threonine Industrial Chain Analysis
9 Âé¶¹Ô´´ing Channel, Distributors and Customers
9.1 Âé¶¹Ô´´ing Channel
9.2 Threonine Distributors List
9.3 Threonine Customers
10 Threonine Âé¶¹Ô´´ Dynamics
10.1 Threonine Industry Trends
10.2 Threonine Âé¶¹Ô´´ Drivers
10.3 Threonine Âé¶¹Ô´´ Challenges
10.4 Threonine Âé¶¹Ô´´ Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Âé¶¹Ô´´ Size Estimation
12.1.1.3 Âé¶¹Ô´´ Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
Meihua
Ajinomoto Group
CJ CheilJedang
Evonik
Fufeng
NB Group
Star Lake Bioscience
Guoguang Biochemistry
GLOBAL Bio-Chem
ADM
Ìý
Ìý
*If Applicable.
